Regulation of the Na/K ATPase by protein kinases is model-specific. We have observed a profound activation of the sarcolemmal Na/K ATPase during cardiac ischemia, which is masked by an inhibitor of the enzyme in the cytosol. The aim of these studies was to characterize the pathways involved in this activation in the Langendorff-perfused rat heart. Na/K ATPase activity was determined by measuring ouabain-sensitive phosphate generation by cardiac homogenates at 37°C. In isolated sarcolemma, ischemia (30 min) caused a substantial activation of the Na/K ATPase compared with aerobic controls, which was abolished by perfusing the heart with staurosporine or H89. However, the α1 subunit of the Na/K ATPase was not phosphorylated during ischemia. T...
Phospholemman (PLM, FXYD1), abundantly expressed in the heart, is the primary cardiac sarcolemmal su...
Abstract—Intracellular [Na] is3 mmol/L higher in heart failure (HF; in our arrhythmogenic rabbit mod...
Phospholemman (PLM), the principal quantitative sarcolemmal substrate for protein kinases A and C in...
Regulation of the Na/K ATPase by protein kinases is model-specific. We have observed a profound acti...
Objective: Intracellular Na rises rapidly during cardiac ischemia and this has been attributed to th...
Objective: Intracellular Na rises rapidly during cardiac ischemia and this has been attributed to th...
Objective: Intracellular Na rises rapidly during cardiac ischemia and this has been attributed to th...
Objective: Intracellular Na rises rapidly during cardiac ischemia and this has been attributed to th...
Cardiac Na/K-ATPase (NKA) is regulated by its accessory protein phospholemman (PLM). Whereas kinase-...
Cardiac Na/K-ATPase (NKA) is regulated by its accessory protein phospholemman (PLM). Whereas kinase-...
In cardiac muscle, the sarcolemmal sodium/potassium ATPase is the principal quantitative means of ac...
In cardiac muscle, the sarcolemmal sodium/potassium ATPase is the principal quantitative means of ac...
In cardiac muscle, the sarcolemmal sodium/potassium ATPase is the principal quantitative means of ac...
In cardiac muscle, the sarcolemmal sodium/potassium ATPase is the principal quantitative means of ac...
Phospholemman (PLM, FXYD1), abundantly expressed in the heart, is the primary cardiac sarcolemmal su...
Phospholemman (PLM, FXYD1), abundantly expressed in the heart, is the primary cardiac sarcolemmal su...
Abstract—Intracellular [Na] is3 mmol/L higher in heart failure (HF; in our arrhythmogenic rabbit mod...
Phospholemman (PLM), the principal quantitative sarcolemmal substrate for protein kinases A and C in...
Regulation of the Na/K ATPase by protein kinases is model-specific. We have observed a profound acti...
Objective: Intracellular Na rises rapidly during cardiac ischemia and this has been attributed to th...
Objective: Intracellular Na rises rapidly during cardiac ischemia and this has been attributed to th...
Objective: Intracellular Na rises rapidly during cardiac ischemia and this has been attributed to th...
Objective: Intracellular Na rises rapidly during cardiac ischemia and this has been attributed to th...
Cardiac Na/K-ATPase (NKA) is regulated by its accessory protein phospholemman (PLM). Whereas kinase-...
Cardiac Na/K-ATPase (NKA) is regulated by its accessory protein phospholemman (PLM). Whereas kinase-...
In cardiac muscle, the sarcolemmal sodium/potassium ATPase is the principal quantitative means of ac...
In cardiac muscle, the sarcolemmal sodium/potassium ATPase is the principal quantitative means of ac...
In cardiac muscle, the sarcolemmal sodium/potassium ATPase is the principal quantitative means of ac...
In cardiac muscle, the sarcolemmal sodium/potassium ATPase is the principal quantitative means of ac...
Phospholemman (PLM, FXYD1), abundantly expressed in the heart, is the primary cardiac sarcolemmal su...
Phospholemman (PLM, FXYD1), abundantly expressed in the heart, is the primary cardiac sarcolemmal su...
Abstract—Intracellular [Na] is3 mmol/L higher in heart failure (HF; in our arrhythmogenic rabbit mod...
Phospholemman (PLM), the principal quantitative sarcolemmal substrate for protein kinases A and C in...